Abstract
Background/Aims
The aim of this study was to determine the clinical performances of noninvasive serum markers for the prediction of liver fibrosis in chronic viral liver diseases. Methods: We analyzed a total of 225 patients with chronic viral liver diseases (180 with hepatitis B virus, 43 with hepatitis C virus, and 2 with hepatitis B+C virus) who underwent a liver biopsy procedure at the Hanyang University Guri Hospital between March 2002 and February 2007. Serum was also obtained at the time of liver biopsy. Liver fibrosis was staged according to the scoring system proposed by the Korean Study Group for the Pathology of Digestive Diseases. Various noninvasive serum markers were evaluated, including the aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ratio (AAR), age-platelet (AP) index, AST/platelet ratio index (APRI), cirrhosis discriminant score (CDS), platelet count, hyaluronic acid (HA), and type IV collagen. Results: There were 17, 40, 61, 74, and 33 patients at stages F0, F1, F2, F3, and F4, respectively. The overall diagnostic accuracies of each marker, as determined by the area under receiver operating characteristics curves, were APRI=0.822, CDS=0.776, platelet count=0.773, AP index=0.756, HA=0.749, type IV collagen=0.718, and AAR=0.642 for predicting significant fibrosis (≥F2); and CDS=0.835, platelet count=0.795, AP index=0.794, HA=0.766, AAR=0.711, type IV collagen=0.697, and APRI=0.691 for predicting extensive fibrosis (≥F3). Conclusions: Conclusions: All noninvasive serum markers evaluated in this study were useful for predicting significant or extensive liver fibrosis in chronic viral liver diseases. In particular, APRI was most useful for the prediction of significant fibrosis, and CDS was most useful for the prediction of extensive fibrosis. (Korean J Hepatol 2009;15:454-463)
Citations
Citations to this article as recorded by
- Assesmentof Fibro Q test, AAR & APRI indices as markers of fibrosis in chronic liver disease
Ambresh Ayyali, Shilpa A
IP Indian Journal of Neurosciences.2021; 7(1): 39. CrossRef - Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian Patients
Dalia Omran, Rania A. Zayed, Mohammed M. Nabeel, Lamiaa Mobarak, Zeinab Zakaria, Azza Farid, Mohamed Hassany, Sameh Saif, Muhammad Mostafa, Omar Khalid Saad, Ayman Yosry
Viral Immunology.2018; 31(4): 315. CrossRef - Fibro markers for prediction of hepatocellular carcinoma in Egyptian patients with chronic liver disease
Lamiaa Mobarak, Dalia Omran, Mohammed M. Nabeel, Zeinab Zakaria
Journal of Medical Virology.2017; 89(6): 1062. CrossRef - Multiple approaches to assess fourteen non-invasive serum indexes for the diagnosis of liver fibrosis in chronic hepatitis C patients
María Jesús Andrés-Otero, Ignacio De-Blas-Giral, Juan José Puente-Lanzarote, Trinidad Serrano-Aulló, María José Morandeira, Sara Lorente, José Manuel Lou-Bonafonte
Clinical Biochemistry.2016; 49(7-8): 560. CrossRef - Serum HBsAg and HBeAg levels are associated with liver pathological stages in the immune clearance phase of hepatitis B virus chronic infection
DA-WU ZENG, YU-RUI LIU, JING DONG, YUE-YONG ZHU, YOU-BING LI, JING CHEN, QI ZHENG, JIA-JI JIANG
Molecular Medicine Reports.2015; 11(5): 3465. CrossRef - Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring
Basem Hasan Elesawy, Amal Abd El hafez, Laila Shehata Dorgham, Ahmad El-Askary
Pathology - Research and Practice.2014; 210(12): 922. CrossRef - Noninvasive Biomarkers of Liver Fibrosis: An Overview
Hind I. Fallatah
Advances in Hepatology.2014; 2014: 1. CrossRef - Evaluation of Automated Assays for Measuring Serum Hyaluronic Acid: For the Diagnosis of Rheumatoid Arthritis
Mi-Soon Han, Yongjung Park, Hyon-Suk Kim
Laboratory Medicine Online.2014; 4(2): 98. CrossRef - Real time shear wave elastography in chronic liver diseases: Accuracy for predicting liver fibrosis, in comparison with serum markers
Jae Yoon Jeong
World Journal of Gastroenterology.2014; 20(38): 13920. CrossRef - Diagnostic potential of serum direct markers and non‐invasive fibrosis models in patients with chronic hepatitis B
Özge Gümüşay, Seren Özenirler, Ayşegül Atak, Cemile Sönmez, Seçil Özkan, Ayşe Fıtnat Tuncel, Güldal Yılmaz, Gülen Akyol
Hepatology Research.2013; 43(3): 228. CrossRef - Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B‐related hepatocellular carcinoma following radiofrequency ablation
Ji Yeon Seo, Won Kim, Jee Hye Kwon, Eun Hyo Jin, Su Jong Yu, Hwi Young Kim, Yong Jin Jung, Donghee Kim, Yoon Jun Kim, Jung‐Hwan Yoon, Hyo‐Suk Lee
Liver International.2013; 33(6): 884. CrossRef - Serum Ceruloplasmin Levels Correlate Negatively with Liver Fibrosis in Males with Chronic Hepatitis B: A New Noninvasive Model for Predicting Liver Fibrosis in HBV-Related Liver Disease
Da-Wu Zeng, Yu-Rui Liu, Jie-Min Zhang, Yue-Yong Zhu, Su Lin, Jia You, You-Bing Li, Jing Chen, Qi Zheng, Jia-Ji Jiang, Jing Dong, Anand S Mehta
PLoS ONE.2013; 8(10): e77942. CrossRef - Diagnostic value of multiple biomarker panel for prediction of significant fibrosis in chronic hepatitis C
Seung Ha Park, Chang Hoon Kim, Dong Joon Kim, Ki Tae Suk, Jong Ha Park, Jae Youn Cheong, Sung Won Cho, Seong Gyu Hwang, Youn Jae Lee, Mong Cho, Jin Mo Yang, Ha Young Park, Young Bae Kim
Clinical Biochemistry.2011; 44(17-18): 1396. CrossRef - Ultrasound versus biological markers in the evaluation of periportal fibrosis in human Schistosoma mansoni
Ana Lúcia Coutinho Domingues, Tibério Batista de Medeiros, Edmundo Pessoa de Almeida Lopes
Memórias do Instituto Oswaldo Cruz.2011; 106(7): 802. CrossRef
